You have 9 free searches left this month | to do more

Lenalidomide

Lenalidomide is a drug used to treat Multiple Myeloma, Chronic Lymphocytic Leukemia, Lymphoma, and other conditions. Lenalidomide is being actively studied in 277 studies and prior, has been studied in 263.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterMayo ClinicIrene Ghobrial, MD
National Cancer Institute (NCI)Washington University School of MedicineJacob Laubach
CelgeneRoswell Park Cancer InstituteZhao Weili
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
S
Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
2022-03-22
Mar 22, 2022
A
Active, not recruiting
  • Lymphoma
  • Lenalidomide
  • Philadelphia, Pennsylvania
    Jakub Svoboda
2021-10-04
Oct 4, 2021
M
Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2022-02-17
Feb 17, 2022
U
Completed
  • Acute Myeloid Leukemia
  • Lenalidomide
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill - Lineberger Compreh
2022-01-25
Jan 25, 2022
K
Recruiting
  • Multiple Myeloma
  • Busan, Western, Korea, Republic of
    Kosin University Gospel Hospital
2022-03-31
Mar 31, 2022
D
Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Lenalidomide
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2022-02-11
Feb 11, 2022
U
Active, not recruiting
  • Lymphoma
  • Rituximab
  • Lenalidomide
  • Sacramento, California
    University of California Davis Cancer Center
2021-11-15
Nov 15, 2021
N
Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Lenalidomide
  • XRT, 54-59.4 Gy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-12-30
Dec 30, 2021
F
Active, not recruiting
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
2022-04-04
Apr 4, 2022
W
Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
2022-02-01
Feb 1, 2022
B
Recruiting
  • EBV Infection
  • PD1 antibody
  • lenalidomide
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
2022-01-04
Jan 4, 2022
U
Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-06-29
Jun 29, 2021
U
Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Lenalidomide
  • Sacramento, California
    University of California Davis
2022-03-08
Mar 8, 2022
W
Completed
  • Chronic Lymphocytic Leukemia
  • New York, New York
    Weill Cornell Medical College
2021-12-23
Dec 23, 2021
M
Completed
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Laboratory Biomarker Analysis
  • Lenalidomide
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-17
Dec 17, 2021
T
Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Anti-PD-1 monoclonal antibody
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
2021-12-21
Dec 21, 2021
S
Recruiting
  • Central Nervous System Lymphoma
  • lenalidomide
  • Seongnam-si, Please Select, Korea, Republic of
    Seoul National University Bundang Hospital
2022-02-18
Feb 18, 2022
M
Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-08
Mar 8, 2022
U
Active, not recruiting
  • Non Hodgkin's Lymphoma
  • Sacramento, California
  • +1 more
2021-11-15
Nov 15, 2021
H
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2022-03-18
Mar 18, 2022
S
Recruiting
  • Multiple Myeloma
  • GM-CSF vaccine
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-01-06
Jan 6, 2022
B
Recruiting
  • Relapsed/Refractory Marginal Zone Lymphoma
  • Westbury, New York
    Clinical Research Alliance, Inc.
2022-03-29
Mar 29, 2022
N
Completed
  • Urethral Neoplasms
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022